Response of mouse sarcoma-180 to cis-platin in combination with radiation & hyperthermia

Indian Journal of Medical Research

Volumn 103, Issue JUNE, 1996, Pages 315-322

  Satish Rao, B S ^a   Uma Devi, P ^a  

^a KASTURBA MEDICAL COLLEGE   (India)

Author keywords

Cis platin; Combination treatment; Hyperthermia; Radiation; Regrowth delay; Tumour response; Volume doubling time

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; DRUG EFFICACY; HEAT TREATMENT; MOUSE; NONHUMAN; SARCOMA 180; TEMPERATURE;

ANIMALS; ANTINEOPLASTIC AGENTS; CISPLATIN; COMBINED MODALITY THERAPY; HYPERTHERMIA, INDUCED; MICE; MICE, INBRED BALB C; NEOPLASM TRANSPLANTATION; SARCOMA, EXPERIMENTAL; SURVIVAL ANALYSIS;

EID: 0029895726     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Dewey WC, Hopwood LE, Sapareto SA, Gerweck LE. Cellular responses to combinations of hyperthermia and radiation. Radiology 1977; 123 : 463-74.
2. Ben-Hur E, Bronk VB, Elkind MM. Thermally enhanced radiosensitivity of cultured Chinese hamster cells. Nature 1972; 238 : 209-11.
3. Dahl O. Hyperthermia and drugs. In : Wathmous DJ, Ross MM, editors. Hyperthermia Glasgow : Blackie 1986; 121-53.
4. Herman TS, Sweets CC, White DM, Gerner EW. Effect of rate of heating on lethality due to hyperthermia and selected chemotherapeutic drugs. J Natl Cancer Inst 1982; 68 : 487-92.
5. Hahn GM. Potential for therapy of drugs and hyperthermia. Cancer Res 1979; 39 : 2264-8.
6. Engelhardt R. Hyperthermia and drugs. Recent Results Cancer Res 1987; 104 : 133-203.
7. Herman TS, Teicher BA. Sequencing of trimodality therapy, [cis diaminedichloroplatinum (II) hyperthermia radiation] as determined by tumour growth delay and tumour cell survival in the FSaIIC fibrosarcoma. Cancer Res 1988; 48 : 2693-7.
8. Uma Devi P, Satish Rao BS. Response of mouse sarcoma 180 to bleomycin in combination with radiation and hyperthermia. Strahlentherapie und Onkologie 1993; 169 : 601-7.
9. KrakoffIH. Nephrotoxicity of cis-diamminedichloroplatinum (II). Cancer Treat Rep 1979; 63 : 1523-5.
10. Urano M, Kahn J, Kenton LA. The effect of cis-diamminedichloroplatinum treatment at elevated temperatures on murine fibrosarcoma, FSaII. Int J Hyperthermia 1990; 6 : 563-70.
11. Dewit L. Combined treatment of radiation and cisdiamminedichloroplatinum (II) : A review of experimental and clinical data. Int J Radiat Oncol Biol Phys 1987; 13 : 403- 26.
12. Nias NHW. Radiation biology K. In : Sikora K and Halnan KE, editors. Treatment of cancer. London : Chapman Hall Medical. 1990 : 53-92.
13. Mathews DE, Farewell V. Actuarial survival curves. In : Using and understanding medical statistics, Basel : Karger 1985 : 67-87.
14. Rothman KJ. Synergy and antagonism in cause effect relationships. Am J Epidemiol 1974; 99 : 385-91.
15. Overgaard J, Radacic MM, Grau C. Interaction of hyperthermia and cis-diamminedichloroplatinum (II) alone or combined with radiation in a C3H mammary carcinoma in vivo. Cancer Res 1991; 57 : 707-11.
16. Conners TA, Jones PD, Braddock AR, Khokhar ML. New platinum complexes with antitumor activity. Chem Biol Interact 1972; 5 : 415-25.
17. Pfeffer MR, Tcicher BA, Holden SA, Al-Achi A, Herman TS. The interaction of cisplatin plus etoposide with radiation ± hyperthermia. Int J Radiat Oncol Biol Phys 1990; 19 : 1439-47.
18. Mella O. Combined hyperthermia and cisdiamminedichloroplatinum in BDIX rats with transplanted BT4A tumours. Int J Hypertherm 1985; 1 : 171-83.
19. Barlogie B, Corry P, Drewinko B. In vitro thermochemotherapy of human colon cancer cells with cisdiamminedichloroplatinum (II) and mitomycin C. Cancer Res 1980; 40 : 1165-6.
20. Douple EB, Richmond RC. Radiosensitization of hypoxic tumour cells by cis-and trans-dichlorodiammine platinum (II). Int J Radiat Oncol Biol Phys 1979; 5 : 1369-72.
21. Bartelink H, Kallmann RF, Rapacchietta D, Hart, AAM. Therapeutic enhancement in mice by clinically relevant dose and fractionation schedules of cis-diamminedichloroplatinum (II) and irradiation. Radiother Oncol 1986; 6 : 61-74.
22. Lelieveld P, Scoles MA, Brown JM, Kallman RF. The effect of treatment in fractionated schedules with the combination of X-irradiation and six cytotoxic drugs on the RIF-1 tumour and normal mouse skin. Int J Radiat Oncol Biol Phys 1985; 11 : 111-21.
23. Soloway MS, Morris CR, Sudderth B. Radiation therapy and cis-diamminedichloroplatinum (II) in transplantable and primary murine bladder cancer. Int J Radiol Oncol Biol Phys 1979; 5 : 1355-60.